About the DTU
› Home page
Software
› HOMA Calculator
Current Studies
› 4-T
Completed Studies
› ADOPT
Intranet
Search
| A Diabetes Outcomes Progression Trial |  |
 |
|
Organisation |
|
The study is led by an academic steering committee but run operationally and funded by GlaxoSmithKline.
We are grateful to the 4360 participants in 488 North American and European Centres for their help in undertaking this trial.
Study numberClinicalTrials.gov Identifier: NCT00279045 Steering CommitteeS. Kahn, G. Viberti (co-chairs), S. Haffner, W. Herman, R. Holman, N. Jones, J. Lachin, C. O'Neill, and B. Zinman Data Safety Monitoring BoardA. Garber, M. Fisher (co-chairs), H. Dargie, and J. Fuller Safety Analysis Group at University of Wisconsin-MadisonE. Roecker, and T. Havighurst Adjudication CommitteeM. Abrahamson (chair), D. Kelley, and J.-F. Yale ADOPT Study Management TeamA. Phillips, M. Freed, C. O'Neill, B. Kravitz, D. Yu, R. Fowler, K. Saarinen, D. Steele-Norwood, K. Huckel, A. Cobitz, B. Louridas, C. Kirsch, J. Balcarek, and A. Wolstenholme ADOPT Statistics and Data Management TeamM. Heise, G. Paul, J. Koskinas, A. McClatchy, P. Stober, C. Weikert, D. Wade, and J. Wang Study SponsorGlaxoSmithKline |
|
 |
|
|
|
